- Journalists Share Latest on Baby Formula Safety, Estrogen Patches, and Postcancer Costs
- 12 new behavioral health study findings to know
- Prevention Efforts Increasingly See Suicide Through a Broader Lens
- California dental hygiene program placed on probation, accreditation at risk: 5 notes
- US depression rate remains near record high: Gallup
- FDA names acting director of vaccines and biologics center
- We Are Breaking Anesthesia — And Calling It a Staffing Solution
- Establishing Good Governance: Start with the Important Basics and Play the Long Game
- Mission, margin and a midterm clock: Healthcare signals to watch
- What ASC tech actually moves the needle — and what’s just ‘face paint’
- ADA pushes for increased federal oversight of dental insurance: 4 notes
- VisionMed appoints new strategic advisor of ambulatory, office-based surgery
- South Dakota hospital joins Monument Health
- Dental groups call on legislators to support federal oral health programs
- PDS Health joins AARP global collaborative
- Nemours Children’s Health breaks ground on multispecialty facility
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- Physician financial pressures, a breakdown
- Physicians’ wRVU problem, by the numbers
- CMS’ Medicare provider directory released Social Security numbers: Washington Post
- The best ASCs for colonoscopy, endoscopy in the Midwest: US News
- 2 post-acute groups react to bill to improve CNA training
- 32 hospitals closing departments or ending services
- Visa limbo drags on for hundreds of physicians: 5 notes
- Hygienist shortage a ‘retention’ crisis: ADHA
- Yale receives $10M for youth mental health
- PDS Health grows de novo network with 6 new practices
- Penn Medicine, CHOP name autism institute director
- Cleveland Clinic adds GI specialist
- FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype
- A new kind of ASC partner has entered the market
- 8 DSOs making headlines
- Heartland Dental adds Florida practice
- Colorado behavioral health provider to cut 111 jobs
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- SALT Dental Partners opens de novo office in Washington, DC
- Noncompete rules shift again: 4 recent updates
- The 4 states with the most DSO activity in April
- 10 new ASCs in April
- Florida physician sued for alleged $1.9M fraud
- Omada signs on with Optum Rx's GLP-1 management program
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
- Industry Voices—Value-based care won the policy argument. Now it has to deliver
- Senators introduce clean extension to cost-based payments for some rural hospitals
- Expanding access, improving outcomes: How AI is transforming behavioral health referrals
- Beth Israel Lahey Health taps Heidi for system-wide AI scribe rollout
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Cleveland Clinic taps startup Luminai to test how AI can run hospital operations
- Look out Rexulti, Axsome's Auvelity has its nod for Alzheimer's agitation
- Cardio drug developer Esperion to go private in potential $1.1B buyout by ArchiMed
- Union workers at Korean CDMO Samsung Biologics kick off strike
- Summit's PD-1xVEGF interim trial miss surprises analysts, shares tumble
- Who do Americans believe have the most influence in healthcare?
- Health Tech Weekly Rundown: Sage launches Tasking for senior care workflows; St. Luke’s taps Auxira Health for cardiologist support
- Confusion Continues Over Age To Start Breast Cancer Screening, Survey Finds
- Senses, Not Muscles, Key to Speech Recovery After Stroke
- Antibiotics Not Linked To Celiac Disease Risk, Study Argues
- Common Knee Surgery Doesn't Help, Might Actually Make Things Worse, Clinical Trial Reports
- States Rush To Figure Out How To Enforce Trump's Medicaid Work Requirements
- Delays in Visa Program Threaten Placement of Hundreds of Doctors in Underserved Areas
- Gavin Newsom, Early Champion of Single-Payer, Moderates in the Face of Fiscal Limits
- A pivotal time for an RNA pioneer
- Repatha sales help Amgen overcome Prolia biosimilar hits in 1st quarter
- Novo Nordisk’s Rybelsus officially retired in US as ‘Ozempic pill’ takes branding center stage
- Verastem launches ‘Reimagine’ campaign to move ovarian cancer drugs into earlier lines
- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- Mount Sinai launches mental health program for performing artists
- Managing AI in Medical Technology: From Innovation to Compliance
- Managing AI in Medical Technology: From Innovation to Compliance
- Mississippi to distribute $13.5M for youth mental health programs
- ‘Heroism doesn’t scale’: 4 leaders warn of cracks in behavioral health system
- Fierce Pharma Asia—Sun’s $11.75B Organon buy; Astellas’ Xtandi peak; BeOne’s PD-1xVEGF bet
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- The Structural Tension at the Heart of MedTech
- The Structural Tension at the Heart of MedTech
- Cybersecurity Tactics for Medical IoT Devices
- Cybersecurity Tactics for Medical IoT Devices
- From Toddlers to Teens: The Hidden Complexities of Bringing Pediatric Wearables to Market
- From Toddlers to Teens: The Hidden Complexities of Bringing Pediatric Wearables to Market
- Drug use by state in 2026
- DOJ launches West Coast Health Care Strike Force to target fraud in Arizona, Nevada, Northern California
- Tenet Healthcare met Q1's volume curveballs with 'old-fashioned discipline'
- FDA expectations create potential friction in new Form 483 response guidance
- Trump pulls surgeon general nomination of Casey Means, names Nicole Saphier as new pick
- New Medical Guidelines Urge More Fiber, Less Bathroom Scrolling on Your Phone
- Sleep and Anxiety Medications in Pregnancy Appear to Pose Little Harm
- Functional medicine provider Parsley Health now in-network nationwide
- Lilly touts 'encouraging' early days for Foundayo obesity launch, even as GLP-1 pill appears to lag Novo's
- BMS 'well prepared' for Camzyos competition as revenue from new products overtakes legacy portfolio
- Waystar kicks off 2026 with strong growth as it targets AI at $100B RCM labor pool
- Merck's growth products Winrevair, Ohtuvayre trending in opposite directions
- Trump's Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Nasal Spray Flu Vaccines Create 'Battlefield' In Adults' Noses
- Prehabilitation Slashes Post-Op Complications By Half, Review Says
- Understanding Emotions Could Be Key To Quelling Chronic Pain
- Meth Caused 1 In 6 Heart Attacks Over A Decade, Study Finds
- States Rush To Figure Out How To Enforce Trump’s Medicaid Work Requirements
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- Photon, maker of modern prescription infrastructure, nabs $16M to scale
- Cigna to exit ACA market, pursue strategic alternatives for eviCore unit
- Amarox recalls batch of antidepressants in UK over packaging mix-up
- Bayer earns FDA untitled letter for Nubeqa's 'attention-grabbing visuals'
- Merck bats for heart disease awareness with new baseball-inspired campaign
- Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs
- Europe’s drug regulator sets up new group to counter vaccine hesitancy
- Aidoc banks $150M backed by Goldman Sachs to scale clinical AI foundation model
- Healthcare costs remain a top concern for voters as midterms loom: KFF
- Nonprofit health systems are falling short on governance capabilities, report warns
- Novartis rounds out $23B US investment push with plans for North Carolina API plant
- Teladoc Health reports strong momentum behind BetterHelp insurance shift, CEO says
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- Viz.ai partners with National Rural Health Association to expand AI understanding, access to rural hospitals
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- AstraZeneca CEO's conservative MFN model excludes reference markets from forecast
- With Austedo at helm, Teva's impressive innovative drug sales signal company's successful metamorphosis
- Universal Health Services' Q1 2026 earnings growth dampened by volume hits
- AbbVie outlines Skyrizi defense against new J&J plaque psoriasis rival Icotyde
- Only 1 in 4 employers able to ‘absorb’ increasing health benefit costs without impacting business
- Dementia Screening Safe For Families, Trial Finds
- Online Program Soothes Post-Trauma Stress In Injured Children
- Mental Defeat Can Worsen Chronic Pain, Researchers Say
- Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds
- US drugmaker’s reputations shift quickly amid political pressures, job cuts: survey
- Saving Lives by Changing Lives: The Next Frontier in Suicide Prevention
- Trump’s Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- The push to expand access to emergency contraception
- Secret to Surviving 'Perfect Mom' Posts on Social Media Revealed
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Getting All Your Ducks in a Row to IPO: Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Remarks to the Small Business Capital Formation Advisory Committee
- CDC Warns of Antibiotic-Resistant Salmonella in Backyard Flocks
- Listen to the Latest ‘KFF Health News Minute’
- AI-driven coding platform Arintra rolls out new documentation improvement capabilities
- Florida Delays Children's Health Insurance Expansion as Uninsured Rate Rises
- Daylight Saving Time Fails to Boost Daily Steps, Study Finds
- Metabolic Syndrome Tied To Cancer Risk
- Mail-In Colon Cancer Test Kits Offer Affordable Screening
- U.S. Dentists Still Overprescribing Opioids Compared To Other Nations, Puerto Rico
- An Urgent Care Treated Her Allergic Reaction. An ER Monitored Her — For $6,700.
- Estrogen Patch Shortages Likely Driven By Empowered Women Seeking Relief, Expert Says
- First Gene Therapy for Genetic Hearing Loss, Otarmeni, Gains FDA Approval
Several business news outlets are reporting that the board of Rite Aid is considering another bankruptcy:
Rite Aid weighs repeat bankruptcy filing, WSJ reports
By Reuters - April 4, 2025April 4 (Reuters) - U.S. pharmacy chain Rite Aid is weighing a possible repeat bankruptcy after its recent financial restructuring failed to put the drugstore chain on a sustainable path, the Wall Street Journal reported on Friday.
The company has also been pursuing a sale of some or all of its businesses as a potential alternative to a Chapter 11 filing, the WSJ report said, citing people familiar with the matter.
If a sale doesn't materialize either inside or outside of bankruptcy, the pharmacy chain stands at risk of liquidating more of its footprint, the report added.
Rite Aid did not immediately respond to a Reuters request for comment.
The Pennsylvania-based company emerged from Chapter 11 bankruptcy and successfully completed its financial restructuring last year, operating as a private company.
The pharmacy has used its bankruptcy to close hundreds of stores, sell its pharmacy benefit company Elixir and negotiate settlements with its lenders, drug distribution partner McKesson (MCK.N), opens new tab and other creditors.
Rite Aid filed for Chapter 11 in October 2023, after reporting $750 million in losses and $24 billion in revenue for the fiscal year ended March 2023. It operated 2,000 pharmacies at the time of its bankruptcy.
Rite Aid says it plans to keep its 1,350 stores in 15 states open, but this may be the end for the 63 year old chain: despite filing for bankruptcy again.
https://www.upi.com/Top_News/US/2025/05/05/Rite-Aid-bankruptcy-again/2311746482815/
Rite Aid files for bankruptcy for second time in 18 months
By Allen Cone - May 5, 2025May 5 (UPI) -- Rite Aid on Monday announced it is filing for bankruptcy and looking for a new buyer, just seven months after exiting Chapter 11.
Eighteen months ago, Rite Aid first filed for bankruptcy in October 2023 because it couldn't compete against bigger chains and paid millions for filling unlawful opioid prescriptions. The company plans to keep open its 1,350 stores in 15 states with 4,000 employees.
"For more than 60 years, Rite Aid has been a proud provider of pharmacy services and products to our loyal customers," Matt Schroeder, Rite Aid's CEO, said a statement. "While we have continued to face financial challenges, intensified by the rapidly evolving retail and healthcare landscapes in which we operate, we are encouraged by meaningful interest from a number of potential national and regional strategic acquirers.
"As we move forward, our key priorities are ensuring uninterrupted pharmacy services for our customers and preserving jobs for as many associates as possible."
Rite Aid secured $1.9 billion in new financing, along with cash from operations, and is expected to provide sufficient funding during the sale and court-supervised process," according to a Rite Aid release.
The company intends to divest or monetize any assets not sold through the court-supervised process.
During the first Chapter 11 process, the company slashed $2 billion in debt, secured $2.5 billion in funds to keep operating and closed about 500 locations.
Rite Aid, which is headquartered in Philadelphia, had revenue of $24.06 billion in 2023 but a $750 million net loss, according to its filing.
Rite Aid is the third-largest nationwide standalone pharmacy chain in the United States far behind CVS's 9,118 and Walgreens with 8,363. CVS also has 1,865 retail pharmacies within retail chains and approximately 80 clinics in Target stores.
When counting big box chains, such as Walmart, it is the seventh-largest pharmacy in the United States. Also Amazon is now selling prescription drugs.
In 2015, Walgreens offered $17 billion to acquire the company, but U.S. regulators were fearful the combination would violate federal antitrust laws and reduce competition in the market.
In 2017, the companies agreed to a $4.4 billion deal in which Walgreens acquired 1,932 of the 4,000 Rite Aid locations.
Rite Aid's peak in 2008 was 5,059 stores. Rite Aid opened its first store in 1962 in Scranton, Pa., and now is mainly in New York, California and Pennsylvania.
Walgreens announced in March that it was going private in a deal valued up to $24 billion. The transaction is expected to be finalized later this year.
CVS has closed more than 1,000 stores and undergone thousands of layoffs.
Rite Aid has begun selling off its "pharmacy assets". In some cases entire stores, in others prescription and customer files:
Rite Aid to sell 1,000 pharmacy assets to CVS, Walgreens and others
By Sabrina Valle - May 15, 2025May 15 (Reuters) - Bankrupt U.S. pharmacy chain Rite Aid on Thursday said it agreed to sell pharmacy assets from more than 1,000 store locations in separate transactions to CVS Pharmacy, Walgreens, Albertsons, Kroger and Giant Eagle, among others.
CVS Pharmacy will buy and operate many Rite Aid and Bartell Drugs stores in Washington, Oregon and Idaho, Rite Aid said in a filing.
Rite Aid stores will remain open, and customers can continue to use pharmacy services, including prescription refills and immunizations, without interruption, it said.
The sale includes prescription files and other goods, a person familiar with the agreements said.
Walgreens declined to comment. The other bidders did not immediately respond to requests for comment.
Earlier this month, Rite Aid filed for bankruptcy for the second time in less than two years, after poor performance in its retail business made it difficult for the company to maintain sufficient cash flow and restock its retail inventory.
The company has received court approval to pursue a rapid-fire sale of its pharmacy business. Rite Aid is scheduled to conduct a hearing to approve the sales on May 21. The sales will remain subject to regulatory notices and approvals.
The Pennsylvania-based company entered bankruptcy with over $2 billion in debt and has warned employees about likely job cuts. Rite Aid Chief Executive Matt Schroeder said on Thursday the company would try to preserve jobs during the transition.
"These agreements ensure our pharmacy customers will experience a smooth transition while preserving jobs for some of our valued team members," Schroeder said in a note.
Bloomberg had previously reported on CVS' bid.
Rite Aid had about 1,350 pharmacies, so the fate of the remaining 350 pharmacies is yet to be explained.
And they're gone for good:
https://www.cbsnews.com/news/rite-aid-closing-all-locations-after-decades-in-business/
Rite Aid closing all locations after decades in business
October 4, 2025 / 9:34 PM EDT / CBS NewsRite Aid is closing all locations, according to a recent post on the U.S. pharmacy chain's website.
"All Rite Aid stores have now closed. We thank our loyal customers for their many years of support," read a post at the bottom of the Rite Aid website.
CBS News reached out to Rite Aid for comment on Saturday.
Rite Aid filed for bankruptcy in May, the second such filing in nearly two years. The company also filed for bankruptcy in October 2023 and said at the time that the restructuring would "significantly reduce the company's debt" while helping to "resolve litigation claims in an equitable manner." Rite Aid said it planned to close down 154 stores after the filing.
The company obtained $3.45 billion in fresh financing as it carried out a restructuring plan and dealt with dips in sales and opioid-related lawsuits.
More than 520 Rite Aid pharmacies have closed since October 2023, which is about a quarter of the 2,111 open at the time of the bankruptcy filing.
The Justice Department filed a complaint against Rite Aid in March 2023, accusing the company of violating the False Claims Act and the Controlled Substances Act by filling unlawful prescriptions for drugs such as oxycodone, fentanyl and benzodiazepine and ignoring internal red flags about the prescriptions, CBS News reported.
The website for the company founded in 1962 now only shows a service to help former customers find a new pharmacy and a link to request pharmacy records.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















